@ARTICLE{Larijani, author = {Hasanzad, Mandana and Larijani, Bagher and }, title = {The Pathway from Gene Therapy to Genome Editing: A Nightmare or Dream}, volume = {8}, number = {2}, abstract ={The gene therapy approach has largely been improved by the development of new methods in gene transfer and genome editing. The use of CART cells was first approved in 2018 by FDA for ex vivo treatment of B cell acute lymphoblastic leukemia and in vivo treatment of retinal dystrophy. This revolutionary trend is expected to continue as the clinical vision develops and the technical capacity improves. }, URL = {http://ijmcmed.org/article-1-1042-en.html}, eprint = {http://ijmcmed.org/article-1-1042-en.pdf}, journal = {International Journal of Molecular and Cellular Medicine}, doi = {10.22088/IJMCM.BUMS.8.2.69}, year = {2019} }